From Anxiety to Autism: CBD’s Broad Potential in Psychiatry Highlighted
Recent research into cannabidiol (CBD), a non-psychoactive cannabinoid, shows promising signs for the treatment of several psychiatric conditions, according to a critical review of existing studies. The review focused on clinical studies published before July 27, 2023, scrutinizing the effects of CBD on conditions such as schizophrenia, substance use disorders (SUDs), anxiety, post-traumatic stress disorder … Read more